Hammertoe
is a bending deformity of one or both joints of the second, third, fourth or
fifth toes. The problem happens due to an imbalance in ligaments & muscles
that hold the toe straight. It bends the toe downward instead of keeping it
straight. One of the key reason causing this problem includes wearing a small
size or narrow shoes that bend the toe. Besides this, some other reasons that
can cause hammertoe include rheumatoid arthritis, vein or muscle damage,
Charcot–Marie–Tooth disease, osteoarthritis, stroke, and other feet problems.
The discomfort or pain caused due to hammertoe can be controlled by changing
the footwear. Generally, hammertoe occurs owing to wrong selection of shoes
which affects toe muscles, but in some cases, the problem may be present by
birth itself.
According
to study, “Global
Hammertoe Market Research Report: by Type (Flexible, Rigid), by Treatment
(Implant, Surgery, Others), by Diagnosis (X-Rays, Physical Examinations, and
Others), by End-user (Physiotherapy & Orthopedic Centers, Hospitals &
Clinics, and Others), and Region - Forecast to 2023” the key companies
operating in the global hammertoe market are Arrowhead Medical Device
Technologies LLC, BioPro, Stryker, Extremity Medical LLC, Nextremity Solutions
Inc., Wright Medical Group N.V., Smith & Nephew Plc., Zimmer Biomet,
Centric Medical LLC, Ossio, Pantheon, Generex Biotechnology Corp., Integra
LifeSciences Corporation. Össur, Acumed LLC, Orthofix Holdings, Inc. The key
players are functioning more certainly for leading the high value of market
share and governing the highest market growth.
Based
on type, hammertoe market is segmented into rigid hammer toes and flexible hammer
toes. Based on treatment, market is segmented into orthotic devices, drugs,
surgery and others. Based on non-surgical treatment, market is segmented into
changes in shoe-wear, padding corns & calluses, medications and orthotic
devices. Based on diagnosis, market is segmented into x-rays, physical
examination and others. In addition, based on end-users, market is segmented
into clinics, orthopedic centers, hospitals, physiotherapy and others.
The
hammertoe market is driven by increase in a prevalence of arthritis among the
population, followed by improvement in regulatory policies, rise in number of
geriatric population and growth in research & development (R&D)
expenditure in the pharmaceutical industry. However, lack of awareness among
people, hospital stay associated & pain and problems associated with
surgery may impact the market. Moreover, growth in technological advancements
in hammertoe products is a key opportunity for market.
Based
on geography, the North-American region dominates the hammertoe market owing to
growth in advanced medical facilities, rise in availability of top-class
healthcare infrastructure, and rapid adoption of new products & treatments
in the region. The European and Asian-Pacific regions are estimated to witness
substantial growth rate due to growth in availability of skilled health
professionals, high purchasing power and surge in availability of products over
the forecast period. The market is anticipated to grow at 10.8% CAGR by
reaching the valuation of US $288.61 Million during the forecast period
(2018-2023).
To know more, click on
the link below:-
Contact Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
No comments:
Post a Comment